Biomarkers and acute kidney injury: dining with the Fisher King?

Bouman, Catherine S. C.; Forni, Lui G.; Joannidis, Michael
March 2010
Intensive Care Medicine;Mar2010, Vol. 36 Issue 3, p381
Academic Journal
The author reflects on biomarkers and acute kidney injury. He reports that despite limited utility, serum creatinine remains an essential part for the diagnosis of acute kidney injury(AKI). referring to several studies, he explains that performance biomarkers like serum neutrophil gelatinase-associated lipocalin (NGAL) and Ang-2 addresses specific applications in AKI. He also discusses the role of NGAL in critically ill patients.


Related Articles

  • Biomarkers of acute kidney injury in neonatal encephalopathy. Sweetman, DU; Molloy, EJ // European Journal of Pediatrics;Mar2013, Vol. 172 Issue 3, p305 

    Acute kidney injury (AKI) is a common complication of neonatal encephalopathy (NE). The accurate diagnosis of neonatal AKI, irrespective of the cause, relies on suboptimal methods such as identification of rising serum creatinine, decreased urinary output and glomerular filtration rate. Studies...

  • Delta Neutrophil Index as a Promising Prognostic Marker in Out of Hospital Cardiac Arrest. Yune, Ho Young; Chung, Sung Phil; Park, Yoo Seok; Chung, Hyun Soo; Lee, Hye Sun; Lee, Jong Wook; Park, Jong Woo; You, Je Sung; Park, Incheol; Lee, Hahn Shick // PLoS ONE;Mar2015, Vol. 10 Issue 3, p1 

    Background: The post-resuscitation phase after out-of-hospital cardiac arrest (OHCA) is characterised by a systemic inflammatory response (e.g., severe sepsis), for which the immature granulocyte count is a diagnostic marker. In this study we evaluated the prognostic significance of the delta...

  • Plasma YKL-40 and all-cause mortality in patients with chronic obstructive pulmonary disease. Holmgaard, Dennis B.; Mygind, Lone H.; Titlestad, Ingrid L.; Madsen, Hanne; Pedersen, Svend Stenvang; Johansen, Julia S.; Pedersen, Court // BMC Pulmonary Medicine;2013, Vol. 13 Issue 1, p1 

    Background Chronic obstructive pulmonary disease (COPD) is hallmarked by inflammatory processes and a progressive decline of lung function. YKL-40 is a potential biomarker of inflammation and mortality in patients suffering from inflammatory lung disease, but its prognostic value in patients...

  • Comment on Association Between Coronary Artery Ectasia and Neutrophil–Lymphocyte Ratio. İşçen, Sinan // Angiology;Nov2013, Vol. 64 Issue 8, p633 

    The article presents the author's comments on the study "Association between coronary artery ectasia and neutrophil lymphocyte ratio," by S. Balta and colleagues. According to the author, the study shows unnecessary distinction between coronary artery disease (CAD) and coronary artery ectasia...

  • A transcriptomic reporter assay employing neutrophils to measure immunogenic activity of septic patients' plasma. Khaenam, Prasong; Rinchai, Darawan; Altman, Matthew C; Chiche, Laurent; Buddhisa, Surachat; Kewcharoenwong, Chidchamai; Suwannasaen, Duangchan; Mason, Michael; Whalen, Elizabeth; Presnell, Scott; Susaengrat, Wattanachai; O'Brien, Kimberly; Nguyen, Quynh-Ahn; Gersuk, Vivian; Linsley, Peter S; Lertmemongkolchai, Ganjana; Chaussabel, Damien // Journal of Translational Medicine;2014, Vol. 12 Issue 1, p1 

    Background: There are diverse molecules present in blood plasma that regulate immune functions and also present a potential source of disease biomarkers and therapeutic targets. Genome-wide profiling has become a powerful method for assessing immune responses on a systems scale, but technologies...

  • Chlorotyrosine protein adducts are reliable biomarkers of neutrophil-induced cytotoxicity in vivo. Gujral, Jaspreet S.; Hinson, Jack A.; Jaeschke, Hartmut // Comparative Hepatology;2004 Supplement 1, Vol. 3, p1 

    Introduction: A limitation for investigating the pathophysiological role of neutrophils in vivo is the lack of a reliable biomarker for neutrophil cytotoxicity in the liver. Therefore, we investigated if immunohistochemical detection of chlorotyrosine protein adducts can be used as a specific...

  • The Neutrophil–Lymphocyte Ratio and Behcet Disease. Acikgoz, Nusret // Angiology;Mar2016, Vol. 67 Issue 3, p297 

    A letter to the editor is presented in response to the article "Neutrophil-lymphocyte ratio and carotid-intima media thickness in patients with Behçet disease without cardiovascular involvement" by C. Ozturk and others, in a 2015 issue.

  • The Neutrophil–Lymphocyte Ratio and Inflammation. Balta, Sevket; Ozturk, Cengiz; Balta, Ilknur; Demirkol, Sait; Demir, Mustafa; Celik, Turgay; Iyisoy, Atila // Angiology;Mar2016, Vol. 67 Issue 3, p298 

    A response from the author of the article "Neutrophil-lymphocyte ratio and carotid-intima media thickness in patients with Behçet disease without cardiovascular involvement" in a 2015 issue is presented.

  • PR3-ANCA: A Promising Biomarker in Primary Sclerosing Cholangitis (PSC). Stinton, Laura M.; Bentow, Chelsea; Mahler, Michael; Norman, Gary L.; Eksteen, Bertus; Mason, Andrew L.; Kaplan, Gilaad G.; Lindkvist, Bjorn; Hirschfield, Gideon M.; Milkiewicz, Piotr; Cheung, Angela; Janssen, Harry L. A.; Fritzler, Marvin J. // PLoS ONE;Nov2014, Vol. 9 Issue 11, p1 

    Background and Aims: The only recognized biomarker for primary sclerosing cholangitis (PSC) is atypical anti-neutrophil cytoplasmic antibodies (aANCA), which, in addition to having low sensitivity and specificity, is an indirect immunofluorescence (IIF) test lacking the advantages of high...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics